⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

October 1, 1997Arthritis & Rheumatism

Trial of intravenous pulse cyclophosphamide and methylprednisolone in the treatment of severe systemic‐onset juvenile rheumatoid arthritis

Carol A. Wallace David D. Sherry

View at Publisher

Ask AI

Bookmark

Share

Abstract

Monthly I.V. pulse CYC treatments can be useful to control disease in selected children with severe, destructive JRA.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Wallace et al. (1997) studied this question.

synapsesocial.com/papers/69da21d00f778bd2e468428f https://doi.org/10.1002/art.1780401019

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1THERAPEUTIC CRITERIA IN RHEUMATOID ARTHRITISOriginal Research · 1949 · 2,878 citations
2A study of classification criteria for a diagnosis of juvenile rheumatoid arthritisOriginal Research · 1986 · 425 citations
3Preliminary criteria for clinical remission in rheumatoid arthritisCohort Study · 1981 · 803 citations
4Use of Testosterone To Prevent Cyclophosphamide-Induced AzoospermiaCohort Study · 1997 · 165 citations
5The Effect of Cyclophosphamide Pulses on Fertility in Patients With Lupus NephritisOriginal Research · 1992 · 73 citations

More from Arthritis & Rheumatism

Rapid Implementation of a Multidisciplinary COVID‐19 Cytokine Storm Syndrome Task ForceSat,
A systematic review exploring pre-COVID-19 telehealthcare models used in the management of patients with rheumatological diseaseFri,
Long-Term Outcome of Temporomandibular Joint Arthritis in Juvenile Idiopathic Arthritis : Results of 18-Year Follow-up in the Population-Based Nordic JIA CohortMon,
Regional Distribution of Adult RheumatologistsWed,
Association of Low Baseline Levels of Erythrocyte Folate With Treatment Nonresponse at Three Months in Rheumatoid Arthritis Patients Receiving MethotrexateMon,